Trial
NCT01989091
Efficacy Study to Evaluate B-Lock™ as an Antimicrobial Lock Solution in Dialysis Patients With a CVC
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Great Lakes Pharmaceuticals Inc.
Collaborators
—
Condition
Dialysis Catheter Infections
Intervention
B-Lock
Why stopped
Did not meet predetermined primary endpoint
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-02-27